The IVW approach employed for genetic prediction demonstrated an association between elevated concentrations of monocyte chemoattractant protein-4 (CCL13) (OR = 1.159, 95% CI 1.020–1.317, P = 0.024), signaling lymphocytic activation molecule (SLAMF1) (OR = 1.261, 95% CI 1.094–1.453, P = 0.001) and tumor necrosis factor ligand superfamily member 14 (TNFSF14) (OR = 1.218, 95% CI 1.056–1.406, P = 0.073) were associated with an increased risk of dry AMD. The gene discussed is CCL13; the disease is dry age related macular degeneration.